Jim Frontero

Jim Frontero is a seasoned executive with extensive experience in the medical device and diagnostics industry. Currently serving as Chief Commercial Officer at Belmont Medical Technologies since 2018, Frontero oversees the development of critical care medical devices for various settings globally. Prior to this role, Frontero held leadership positions at Good Start Genetics, where a strategic sale to Invitae Corporation was successfully completed, and Devicor Medical Products, which was sold to Danaher Corporation under Frontero's strategic guidance. Frontero's earlier experience includes serving as President of Straumann USA, managing a $175M business in the dental sector, and as General Manager at Boston Scientific Corporation, where Frontero directed a $20M global business. Frontero holds an Executive MBA from the Questrom School of Business at Boston University and a Bachelor of Science in Business Administration from Cornell University.